# Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers

> **NCT00809289** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** esreboxetine
- **DRUG:** placebo
- **DRUG:** moxifloxacin

## Key facts

- **NCT ID:** NCT00809289
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809289, "Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00809289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*